omalizumab

Ligand id: 6890

Name: omalizumab

Immunopharmacology Disease
Disease X-Refs Comment References
Chronic idiopathic urticaria An anti-IgE therapy approved to treat antihistamine-resistant chronic idiopathic urticaria .
Asthma Disease Ontology: DOID:2841
OMIM: 600807
An anti-IgE therapy approved to treat persistent and severe asthma inadequately controlled by inhaled corticosteroids.